What Does BPAC Stand For?

BPAC stands for Blood Products Advisory Committee CBER

The Blood Products Advisory Committee (BPAC) is a key advisory body within the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA). BPAC provides expert recommendations on issues related to the safety, effectiveness, and availability of blood products, including vaccines and biologics derived from human blood. The committee plays a critical role in guiding regulatory decisions and policies, ensuring public health and safety in the use of blood-derived therapeutics.